Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07523789) titled 'Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC' on April 5.

Study Type: Observational

Primary Sponsor: The First Affiliated Hospital with Nanjing Medical University

Condition: TNBC, Triple Negative Breast Cancer

Recruitment Status: Not recruiting

Date of First Enrollment: May 1, 2026

Target Sample Size: 201

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07523789

Published by HT Digital Content Services with permission from Health Daily Digest....